REG - Indivior PLC - Transaction in Own Shares

IndiviorAnnouncement

04/02/2025 07:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250204:nRSD7313Va&default-theme=true

RNS Number : 7313V  Indivior PLC  04 February 2025

INDIVIOR PLC

SHARE REPURCHASE PROGRAM

WEEKLY REPORT

February 4, 2025

INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total
of 204,247 of its ordinary shares of $0.50 each through Morgan Stanley &
Co. International Plc in the period from January 27, 2025, up to and including
January 31, 2025, in connection with its $100m Share Repurchase Program.
Aggregated information on the purchase of these shares can be found in the
table below.

Following the purchase and cancellation of the above shares (including those
purchased but not yet settled), Indivior has 124,137,286 ordinary shares of
$0.50 each with voting rights in issue. There are no shares held in treasury.

The above figure (124,137,286) may be used by shareholders (and others with
notification obligations) as the denominator for the calculation by which they
will determine if they are required to notify their interest in, or a change
to their interest in, Indivior under the FCA's Disclosure Guidance and
Transparency Rules.

All repurchases by Indivior are "On Exchange" transactions (as such term is
defined in the rules of the London Stock Exchange) and "on market" for the
purposes of the Companies Act 2006.

Aggregated information

 Trading Date  Trading Venue  Aggregated daily volume (number of shares)  Daily weighted average purchase price of the shares (p)
 27/01/2025    LSE            15,225                                      964.57
 27/01/2025    BATE           5,912                                       963.95
 27/01/2025    CHIX           18,321                                      965.68
 27/01/2025    AQUIS          2,442                                       967.02
 28/01/2025    LSE            20,092                                      982.38
 28/01/2025    BATE           4,586                                       984.79
 28/01/2025    CHIX           14,490                                      982.55
 28/01/2025    AQUIS          2,330                                       985.06
 29/01/2025    LSE            20,652                                      987.47
 29/01/2025    BATE           3,602                                       990.21
 29/01/2025    CHIX           15,514                                      988.73
 29/01/2025    AQUIS          1,068                                       993.23
 30/01/2025    LSE            14,877                                      982.26
 30/01/2025    BATE           7,449                                       983.03
 30/01/2025    CHIX           16,455                                      982.00
 30/01/2025    AQUIS          1,734                                       980.91
 31/01/2025    LSE            9,956                                       979.80
 31/01/2025    BATE           6,684                                       979.75
 31/01/2025    CHIX           19,365                                      976.14
 31/01/2025    AQUIS          3,493                                       990.02

 

 

Transaction details

In accordance with Article 5(1)(b) of the assimilated Market Abuse Regulation
(EU) No 596/2014, as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018 and Commission Delegated Regulation (EU)
2016/1052, a full breakdown of the individual purchases of ordinary shares
made by Morgan Stanley & Co. International Plc on behalf of Indivior
during the above period as part of the Share Repurchase Program can be found
at
www.indivior.com/en/investors/shareholder-information/share-repurchase-program
(http://www.indivior.com/en/investors/shareholder-information/share-repurchase-program)
.

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

Contact:

Jason Thompson

Vice President, Investor Relations

1-804-402-7123

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSGZGGZNFLGKZM